Modulation of the immune system by ouabain

Annals of the New York Academy of Sciences

Volumn 1153, Issue , 2009, Pages 153-163

  Rodrigues Mascarenhas, Sandra ^a   De Oliveira, Andreia Da Silva ^b   Amoedo, Nívea Dias ^b   Affonso Mitidieri, Ottilia R ^b   Rumjanek, Franklin D ^b   Rumjanek, Vivian M ^b  

^a FEDERAL UNIVERSITY OF PARAÍBA   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Immune system; Lymphocytes; MAPK; Na,K ATPase alpha subunit isoforms; Ouabain; p38; Plasma membrane depolarization

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) ALPHA1; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) ALPHA2; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) ALPHA3; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM) INHIBITOR; CONCANAVALIN A; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; OUABAIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

APOPTOSIS; BINDING SITE; CELL ACTIVATION; CELL MEMBRANE; CONCENTRATION RESPONSE; CONFERENCE PAPER; CYTOKINE PRODUCTION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME SUBUNIT; FLUORESCENCE; IMMUNOMODULATION; ION TRANSPORT; LYMPH NODE; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; LYMPHOID CELL; MEMBRANE DEPOLARIZATION; MONOCYTE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THYMOCYTE; THYMUS;

MURINAE; STROPHANTHUS GRATUS;

EID: 60449103121     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2008.03969.x     Document Type: Conference Paper

References (92)

1. Goto, A., K. Yamada, N. Yagi, et al. 1992. Ouabain as endogenous digitalis-like factor in animals? Clin. Chem. 38 : 161 162.
2. Hamlyn, J.M., M.P. Blaustein, S. Bova, et al. 1991. Identification and characterization of a ouabain-like compound from human plasma. Proc. Natl. Acad. Sci. USA 88 : 6259 6263.
3. Ferrandi, M., P. Manunta, S. Balzan, et al. 1997. Ouabain-like factor quantification in mammalian tissues and plasma: comparison of two independent assays. Hypertension 30 : 886 896.
4. Doris, P.A. & D.M. Stocco. 1989. An endogenous digitalis-like factor derived from the adrenal gland: studies of adrenal tissue from various sources. Endocrinology 125 : 2573 2579.
5. Ludens, J.H., M.A. Clark, F.G. Robinson & D.W. DuCharme. 1992. Rat adrenal cortex is a source of a circulating ouabainlike compound. Hypertension 19 : 721 724.
6. Boulanger, B.R., M.P. Lilly, J.M. Hamlyn, et al. 1993. Ouabain is secreted by the adrenal gland in awake dogs. Am. J. Physiol. 264 : 413 419.
7. Laredo J., B.P. Hamilton & J.M. Hamlyn. 1994. Ouabain is secreted by bovine adrenocortical cells. Endocrinology 135 : 794 797.
8. Beck, M., K.S. Szalay, G.M. Nagy, et al. 1996. Production of ouabain by rat adrenocortical cells. Endocr. Res. 22 : 845 849.
9. Hinson, J.P., S. Harwood & A.B. Dawnay. 1998. Release of ouabain-like compound (OLC) from the intact perfused rat adrenal gland. Endocr. Res. 24 : 721 724.
10. Goto, A., K. Yamada, H. Nagoshi, et al. 1995. Stress-induced elevation of ouabainlike compound in rat plasma and adrenal. Hypertension 26 : 1173 1176.
11. Schoner, W., N. Bauer, J. Müller-Ehmsen, et al. 2003. Ouabain as a mammalian hormone. Ann. N. Y. Acad. Sci. 986 : 678 684.
12. Sophocleous, A., I. Elmatzoglou & A. Souvatzoglou. 2003. Circulating endogenous digitalis-like factor(s) (EDLF) in man is derived from the adrenals and its secretion is ACTH-dependent. J. Endocrinol. Invest. 26 : 668 674.
13. Laredo J., J.R. Shah, Z.R. Lu, et al. 1997. Angiotensin II stimulates secretion of endogenous ouabain from bovine adrenocortical cells via angiotensin type 2 receptors. Hypertension 29 : 401 407.
14. Shah, J.R., J. Laredo, B.P. Hamilton & J.M. Hamlyn. 1998. Different signaling pathways mediate stimulated secretions of endogenous ouabain and aldosterone from bovine adrenocortical cells. Hypertension 31 : 463 468.
15. Tymiak, A.A., J.A. Norman, M. Bolgar, et al. 1993. Physicochemical characterization of a ouabain isomer isolated from bovine hypothalamus. Proc. Natl. Acad. Sci. USA 90 : 8189 8193.
16. Zhao, N., L.C. Lo, N. Berova, et al. 1995. Na,K-ATPase inhibitors from bovine hypothalamus and human plasma are different from ouabain: nanogram scale CD structural analysis. Biochemistry 34 : 9893 9896.
17. Yamada, K., A. Goto & M. Omata. 1995. Modulation of the levels of ouabain-like compound by central catecholamine neurons in rats. FEBS Lett. 360 : 67 69.
18. Kawamura, A., J. Guo, Y. Itagaki, et al. 1999. On the structure of endogenous ouabain. Proc. Natl. Acad. Sci. USA 96 : 6654 6659.
19. Huang, B.S., E. Harmsen, H. Yu & F.H. Leenen. 1992. Brain ouabain-like activity and the sympathoexcitatory and pressor effects of central sodium in rats. Circ. Res. 71 : 1059 1066.
20. Yamada, K., A. Goto, H. Nagoshi, et al. 1994. Role of brain ouabainlike compound in central nervous system-mediated natriuresis in rats. Hypertension 23 : 1027 1031.
21. Budzikowski, A.S. & F.H. Leenen. 1997. Brain 'ouabain' in the median preoptic nucleus mediates sodium-sensitive hypertension in spontaneously hypertensive rats. Hypertension 29 : 599 605.
22. Monteith, G.R. & M.P. Blaustein. 1998. Different effects of low and high dose cardiotonic steroids on cytosolic calcium in spontaneously active hippocampal neurons and in co-cultured glia. Brain Res. 795 : 325 340.
23. de Wardener, H.E. 2001. The hypothalamus and hypertension. Physiol. Rev. 81 : 1599 1658.
24. Xiao, A.Y., L. Wei, S. Xia, et al. 2002. Ionic mechanism of ouabain-induced concurrent apoptosis and necrosis in individual cultured cortical neurons. J. Neurosci. 22 : 1350 1362.
25. de Rezende Corrêa, G., A.A. dos Santos, C.F.L. Fontes & E.G. Araujo. 2005. Ouabain induces an increase of retinal ganglion cell survival in vitro: the involvement of protein kinase C. Brain Res. 1049 : 89 94.
26. Fimbel, S.M., J.E. Montgomery, C.T. Burket & D.R. Hyde. 2007. Regeneration of inner retinal neurons after intravitreal injection of ouabain in zebrafish. J. Neurosci. 27 : 1712 1724.
27. Echevarria-Lima, J. & V. M. Rumjanek. 2006. Effect of ouabain on the immune system. Curr. Hypertens. Rev. 2 : 83 95.
28. Quastel, M. R. & J. G. Kaplan. 1968. Inhibition by ouabain of human lymphocyte transformation induced by phytohaemagglutinin in vitro. Nature 219 : 198 200.
29. Szamel, M., S. Schneider & K. Resch. 1981. Functional interrelationship between (Na+ + K+)-ATPase and lysolecithin acyltransferase in plasma membranes of mitogen-stimulated rabbit thymocytes. J. Biol. Chem. 256 : 9198 9204.
30. de Moraes, V.L., B. Olej, L. de la Rocque & V.M. Rumjanek. 1989. Lack of sensitivity to ouabain in natural killer activity. FASEB J. 3 : 2425 2429.
31. Olej, B., N.F. dos Santos, L. Leal & V.M. Rumjanek. 1998. Ouabain induces apoptosis on PHA-activated lymphocytes. Biosci. Rep. 18 : 1 7.
32. Olej, B., L. de La Rocque, F.P. Castilho, et al. 1994. Effect of ouabain on lymphokine-activated killer cells. Int. J. Immunopharmacol. 16 : 769 774.
33. Brodie, C., A. Tordai, J. Saloga, et al. 1995. Ouabain induces inhibition of the progression phase in human T-cell proliferation. J. Cell. Physiol. 165 : 246 253.
34. Szamel, M., H. Leufgen, R. Kurrle & K. Resch. 1995. Differential signal transduction pathways regulating interleukin-2 synthesis and interleukin-2 receptor expression in stimulated human lymphocytes. Biochim. Biophys. Acta 1235 : 33 42.
35. Jensen, P., L. Winger, H. Rasmussen & P. Nowell. 1977. The mitogenic effect of A23187 in human peripheral lymphocytes. Biochim. Biophys. Acta 496 : 374 383.
36. Redondo, J.M., A. López Rivas & M. Fresno. 1986. Activation of the Na+/K+-ATPase by interleukin-2. FEBS Lett. 206 : 199 202.
37. Pires, V., R.C. Harab, B. Olej & V.M. Rumjanek. 1997. Ouabain effects on activated lymphocytes: augmentation of CD25 expression on TPA-stimulated cells and of CD69 on PHA-and TPA-stimulated cells. Int. J. Immunopharmacol. 19 : 143 148.
38. Stoeck, M., H. Northoff & K. Resch. 1983. Inhibition of mitogen-induced lymphocyte proliferation by ouabain: interference with interleukin 2 production and interleukin 2 action. J. Immunol. 131 : 1433 1437.
39. Lillehoj, H. & E.M. Shevach. 1985. A comparison of the effects of cyclosporin A, dexamethasone, and ouabain on the interleukin-2 cascade. J. Immunopharmacol. 7 : 267 284.
40. Dornand, J., J. Favero, J.C. Bonnafous & J.C. Mani. 1986. Mechanism whereby ouabain inhibits human T lymphocyte activation: effect on the interleukin 2 pathway. Immunobiology 171 : 436 450.
41. Rodrigues-Mascarenhas, S., F.F. Bloise, J. Moscat & V.M. Rumjanek. 2008. Ouabain inhibits p38 activation in thymocytes. Cell Biol. Int. 32 : 1323 1328.
42. Chow, C.W., M. Rincón & R.J. Davis. 1999. Requirement for transcription factor NFAT in interleukin-2 expression. Mol. Cell Biol. 19 : 2300 2307.
43. Esteves, M.B., L.F. Marques-Santos, O.R. Affonso-Mitidieri & V.M. Rumjanek. 2005. Ouabain exacerbates activation-induced cell death in human peripheral blood lymphocytes. An. Acad. Bras. Cienc. 77 : 281 292.
44. Orlov, S.N., N. Thorin-Trescases, S.V. Kotelevtsev, et al. 1999. Inversion of the intracellular Na+/K+ ratio blocks apoptosis in vascular smooth muscle at a site upstream of caspase-3. J. Biol. Chem. 274 : 16545 16552.
45. Gómez-Angelats, M., C.D. Bortner & J.A. Cidlowski. 2000. Protein kinase C (PKC) inhibits fas receptor-induced apoptosis through modulation of the loss of K+ and cell shrinkage. A role for PKC upstream of caspases. J. Biol. Chem. 275 : 19609 19619.
46. Bortner, C.D., F.M. Hughes, Jr. & J.A. Cidlowski. 1997. A primary role for K+ and Na+ efflux in the activation of apoptosis. J. Biol. Chem. 272 : 32436 32442.
47. Hughes, F.M., Jr., C.D. Bortner, G.D. Purdy & J.A. Cidlowski. 1997. Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J. Biol. Chem. 272 : 30567 30576.
48. Kroemer, G., B. Dallaporta & M. Resche-Rigon. 1998. The mitochondrial death/life regulator in apoptosis and necrosis. Annu. Rev. Physiol. 60 : 619 642.
49. Penning, L.C., G. Denecker, D. Vercammen, et al. 2000. A role for potassium in TNF-induced apoptosis and gene-induction in human and rodent tumour cell lines. Cytokine 12 : 747 750.
50. Dornand, J., J. Favero, J.C. Bonnafous & J.C. Mani. 1984. Paradoxical production of mouse thymocyte activating factor by ouabain-treated human mononuclear cells. Cell Immunol. 83 : 351 359.
51. Perregaux, D. & C.A. Gabel. 1994. Interleukin-1 beta maturation and release in response to ATP and nigericin. Evidence that potassium depletion mediated by these agents is a necessary and common feature of their activity. J. Biol. Chem. 269 : 15195 15203.
52. Walev, I., K. Reske, M. Palmer, A. Valeva & S. Bhakdi. 1995. Potassium-inhibited processing of IL-1 beta in human monocytes. EMBO. J. 14 : 1607 1614.
53. Foey, A.D., A. Crawford & N.D. Hall. 1997. Modulation of cytokine production by human mononuclear cells following impairment of Na, K-ATPase activity. Biochim. Biophys. Acta 1355 : 43 49.
54. Matsumori, A., K. Ono, R. Nishio, et al. 1997. Modulation of cytokine production and protection against lethal endotoxemia by the cardiac glycoside ouabain. Circulation 96 : 1501 1506.
55. Matsumori, A., K. Ono, R. Nishio, et al. 2000. Amilodipine inhibits the production of cytokines induced by ouabain. Cytokine 12 : 294 297.
56. Sowa, G. & R. Przewłocki. 1997. Ouabain enhances the lipopolysaccharide-induced nitric oxide production by rat peritoneal macrophages. Immunopharmacology 36 : 95 100.
57. Spivak, J.L., J. Misiti, R. Stuart, et al. 1980. Suppression and potentiation of mouse hematopoietic progenitor cell proliferation by ouabain. Blood 56 : 315 317.
58. Gallicchio, V.S. & M.J. Murphy, Jr. 1981. Erythropoiesis in vitro. IV. Effects of ouabain on erythroid stem cells (CFU-e and BFU-e). Stem Cells 11 : 30 37.
59. Pedersen, K.E. & N.A. Klitgaard. 1983. The characteristics of [3H]-ouabain binding to human lymphocytes. Br. J. Clin. Pharmacol. 15 : 657 665.
60. Blanco, G. & R.W. Mercer. 1998. Isozymes of the Na-K-ATPase: heterogeneity in structure, diversity in function. Am. J. Physiol. 275 : 633 650.
61. Kaplan J.H. 2002. Biochemistry of Na,K-ATPase. Annu. Rev. Physiol. 71 : 511 535.
62. Chow, D.C. & J.G. Forte. 1995. Functional significance of the beta-subunit for heterodimeric P-type ATPases. J. Exp. Biol. 198 : 1 17.
63. Therien, A.G. & R. Blostein. 2000. Mechanisms of sodium pump regulation. Am. J. Physiol. Cell Physiol. 279 : 541 566.
64. Lingrel J.B., M.L. Croyle, A.L. Woo & J.M. Arguello. 1998. Ligand binding sites of Na,K-ATPase. Acta Physiol. Scand. 643 : 69 77.
65. Cantiello H.F. 1995. Actin filaments stimulate the Na(+)-K(+)-ATPase. Am. J. Physiol. 269 : 637 643.
66. Bertorello, A.M., A. Aperia, S.I. Walaas, et al. 1991. Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme. Proc. Natl. Acad. Sci. USA 88 : 11359 11362.
67. Middleton, J.P., W.A. Khan, G. Collinsworth, et al. 1993. Heterogeneity of protein kinase C-mediated rapid regulation of Na/K-ATPase in kidney epithelial cells. J. Biol. Chem. 268 : 15958 15964.
68. Chibalin, A.V., G. Ogimoto, C.H. Pedemonte, et al. 1999. Dopamine-induced endocytosis of Na+,K+-ATPase is initiated by phosphorylation of Ser-18 in the rat alpha subunit and Is responsible for the decreased activity in epithelial cells. J. Biol. Chem. 274 : 1920 1927.
69. Mobasheri, A., J. Ávila, I. Cózar-Castellano, et al. 2000. Na+, K+-ATPase isozyme diversity; comparative biochemistry and physiological implications of novel functional interactions. Biosci. Rep. 20 : 51 91.
70. Mercer, R.W., D. Biemesderfer, D.P. Bliss, Jr., et al. 1993. Molecular cloning and immunological characterization of the gamma polypeptide, a small protein associated with the Na,K-ATPase. J. Cell Biol. 121 : 579 586.
71. Béguin, P., X. Wang, D. Firsov, et al. 1997. The gamma subunit is a specific component of the Na,K-ATPase and modulates its transport function. EMBO. J. 16 : 4250 4260.
72. Forbush, B., 3rd., J.H. Kaplan & J.F. Hoffman. 1978. Characterization of a new photoaffinity derivative of ouabain: labeling of the large polypeptide and of a proteolipid component of the Na, K-ATPase. Biochemistry 17 : 3667 3676.
73. Fontes, C.F.L., F.E.V. Lopes, H.M. Scofano, et al. 1999. Stimulation of ouabain binding to Na,K-ATPase in 40% dimethyl sulfoxide by a factor from Na,K-ATPase preparations. Arch. Biochem. Biophys. 366 : 215 223.
74. Erdmann, E., K. Werdan & L. Brown. 1984. Evidence for two kinetically and functionally different types of cardiac glycoside receptors in the heart. Eur. Heart. J. 5 : 297 302.
75. Sweadner, K.J. 1985. Enzymatic properties of separated isozymes of the Na,K-ATPase. Substrate affinities, kinetic cooperativity, and ion transport stoichiometry. J. Biol. Chem. 260 : 11508 11513.
76. Spach, C. & A. Aschkenasy. 1973. Na and K levels and ATP-ase activity in lymph node, spleen and blood lymphocytes as compared with thymocytes in the male rat. J. Physiol. 66 : 585 592.
77. Rodrigues Mascarenhas, S., J. Echevarria-Lima, N.F. dos Santos & V.M. Rumjanek. 2003. CD69 expression induced by thapsigargin, phorbol ester and ouabain on thymocytes is dependent on external Ca2+ entry. Life Sci. 73 : 1037 1051.
78. Echevarria-Lima, J., E.G. de Araújo, L. de Meis & V.M. Rumjanek. 2003. Ca2+ mobilization induced by ouabain in thymocytes involves intracellular and extracellular Ca2+ pools. Hypertension 41 : 1386 1392.
79. Mann, C.L., C.D. Bortner, C.M. Jewel & J.A. Cidlowski. 2001. Glucocorticoid-induced plasma membrane depolarization during thymocyte apoptosis: association with cell shrinkage and degradation of the Na(+)/K(+)-adenosine triphosphatase. Endocrinology 142 : 5059 5068.
80. Wilson, H.A. & T.M. Chused. 1985. Lymphocyte membrane potential and Ca2+-sensitive potassium channels described by oxonol dye fluorescence measurements. J. Cell. Physiol. 125 : 72 81.
81. Rodrigues-Mascarenhas, S., N.F. dos Santos & V.M. Rumjanek. 2006. Synergistic effect between ouabain and glucocorticoids for the induction of thymic atrophy. Biosci. Rep. 26 : 159 169.
82. Segel, G.B. & M.A. Lichtman. 1980. The apparent discrepancy of ouabain inhibition of cation transport and of lymphocyte proliferation is explained by time-dependency of ouabain binding. J. Cell. Physiol. 104 : 21 26.
83. Saunders, R. & G. Scheiner-Bobis. 2004. Ouabain stimulates endothelin release and expression in human endothelial cells without inhibiting the sodium pump. Eur. J. Biochem. 271 : 1054 1062.
84. Zhu, Z., M. Tepel, M. Neusser & W. Zidek. 1996. Low concentrations of ouabain increase cytosolic free calcium concentration in rat vascular smooth muscle cells. Clin. Sci. 90 : 9 12.
85. Xie, Z. & A. Askari. 2002. Na(+)/K(+)-ATPase as a signal transducer. Eur. J. Biochem. 269 : 2434 2439.
86. +ATPase to growth-related genes in cardiac myocytes - The roles of Ras and mitogen-activated protein kinases. J. Biol. Chem. 273 : 15249 15256.
87. +-ATPase. J. Biol. Chem. 275 : 27832 27837.
88. +-ATPase to ERK1/2. J. Biol. Chem. 276 : 42050 42056.
89. Wu, C.C., S.C. Hsu, H.M. Shih & M.Z. Lai. 2003. Nuclear factor of activated T cells c is a target of p38 mitogen-activated protein kinase in T cells. Mol. Cell Biol. 23 : 6442 6454.
90. Jinlian, L., Z. Yingbin and W. Chunbo. 2007. p38 MAPK in regulating cellular responses to ultraviolet radiation. J. Biomed. Sci. 14 : 303 312.
91. Raingeaud, J., S. Gupta, J. Roger, et al. 1995. Pro-inflammatory cytokines and environmental stress cause p38 MAP kinase activation by dual phosphorylation on tyrosine and threonine. J. Biol. Chem. 270 : 7420 7426.
92. Lasa, M., S.M. Abraham, C. Boucheron, et al. 2002. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38. Mol. Cell Biol. 22 : 7802 7811.